Enoxacin inhibits proliferation and invasion of human osteosarcoma cells and reduces bone tumour volume in a murine xenograft model

Osteosarcoma is the most prevalent primary bone malignancy in children and adolescents. Neoadjuvant chemotherapy combined with surgical resection, the current standard treatment of osteosarcoma, is associated with a 5-year survival rate of only ~70%. Therefore, it is necessary to identify new, more...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xuwen, Liu, Xuqiang, Tao, Qianyuan, Yao, Cong, Wang, Fuqiang, Gu, Zhiping, Li, Feilong, Yu, Xiaolong, Zhang, Bin, Fan, Hongxian, Dai, Min, Nie, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377056/
https://www.ncbi.nlm.nih.gov/pubmed/32724382
http://dx.doi.org/10.3892/ol.2020.11656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377056/
https://www.ncbi.nlm.nih.gov/pubmed/32724382
http://dx.doi.org/10.3892/ol.2020.11656

Ejemplares similares